Research ArticleHuman Studies
“High-Dose” Radioiodine Therapy in Advanced Differentiated Thyroid Carcinoma
Christian Menzel, Frank Grünwald, Axel Schomburg, Holger Palmedo, Hans Bender, Georg Späth and Hans-Jürgen Biersack
Journal of Nuclear Medicine September 1996, 37 (9) 1496-1503;
Christian Menzel
Frank Grünwald
Axel Schomburg
Holger Palmedo
Hans Bender
Georg Späth
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 37, Issue 9
September 1, 1996
“High-Dose” Radioiodine Therapy in Advanced Differentiated Thyroid Carcinoma
Christian Menzel, Frank Grünwald, Axel Schomburg, Holger Palmedo, Hans Bender, Georg Späth, Hans-Jürgen Biersack
Journal of Nuclear Medicine Sep 1996, 37 (9) 1496-1503;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Alternative Means of Estimating 131I Maximum Permissible Activity to Treat Thyroid Cancer
- Dosimetry and thyroid cancer: the individual dosage of radioiodine
- Spatial Dose Mapping for Individualizing Radioiodine Treatment
- Empiric Radioactive Iodine Dosing Regimens Frequently Exceed Maximum Tolerated Activity Levels in Elderly Patients with Thyroid Cancer
- Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
- Antivascular Therapy of Human Follicular Thyroid Cancer Experimental Bone Metastasis by Blockade of Epidermal Growth Factor Receptor and Vascular Growth Factor Receptor Phosphorylation